创伤性胸主动脉损伤腔内与开放修复的远期结局:单中心经验
开放修复组术后急性肾损伤和肠缺血更常见,但两组住院死亡、远期全因死亡及主动脉相关事件无显著差异。
要点
- 开放修复组术后急性肾损伤(47.6% vs 18.9%;P=0.003)和肠缺血(7.1% vs 0.0%;P=0.048)发生率更高。
- 两组住院死亡率(7.1% vs 11.3%;P=0.490)无显著差异。
- 远期全因死亡、主动脉相关死亡及免于主动脉相关事件率两组相似。
核心结论
- 开放修复与TEVAR治疗创伤性胸主动脉损伤的远期生存和主动脉相关事件率相似。
- 开放修复与更高的手术相关并发症发生率相关,尤其是急性肾损伤和肠缺血。
- 解剖条件允许时,研究结果支持TEVAR作为首选治疗方式。
研究设计与样本
- 单中心回顾性队列研究,纳入2003年1月至2024年8月连续95例创伤性胸主动脉损伤患者。
- 主要终点为手术相关并发症和住院死亡率;次要终点为远期全因死亡、主动脉相关死亡及主动脉相关事件率。
- 平均随访129.3±58.8个月。
主要发现
- 开放修复组与TEVAR组术后急性肾损伤发生率分别为47.6%和18.9%(P=0.003)。
- 开放修复组与TEVAR组术后肠缺血发生率分别为7.1%和0.0%(P=0.048)。
- 开放修复组1例(2.4%)发生脊髓缺血,TEVAR组无脊髓缺血发生。
- 开放修复组与TEVAR组脑部并发症发生率分别为4.8%和1.9%(P=0.445),住院死亡率分别为7.1%和11.3%(P=0.490)。
- 开放修复组与TEVAR组远期累积全因死亡率分别为21.4%和18.9%(P=0.915),主动脉相关死亡率分别为2.4%和1.9%(P=0.868),免于主动脉相关事件率比较P=0.813。
临床怎么用
- 在解剖条件允许时,可将TEVAR作为创伤性胸主动脉损伤的首选修复方式。
- 开放修复后需关注急性肾损伤和肠缺血等手术相关并发症。
- TEVAR后仍需长期随访以监测主动脉相关事件。
局限性
- 单中心回顾性设计。
- 样本量有限。
- 需要更大规模多中心研究进一步明确TEVAR的远期疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traumatic thoracic aortic injury (TTAI) carries high early mortality. Thoracic endovascular aortic repair (TEVAR) has increasingly replaced open repair; however, long-term comparative data remain limited. This study compared long-term outcomes after open repair versus TEVAR for TTAI. METHODS: This single-center retrospective cohort study included 95 consecutive patients with TTAI treated between January 2003 and August 2024. Patients with traumatic ascending aortic injury, those managed nonoperatively, or those not undergoing repair were excluded. Forty-two patients underwent open repair, and 53 underwent TEVAR. Primary end points were procedure-related complications and in-hospital mortality. Secondary end points were long-term all-cause and aorta-related mortality and aorta-related event rates. RESULTS: The mean follow-up duration was 129.3 ± 58.8 months. Age and injury severity score were similar between groups. Postoperative acute kidney injury (47.6% vs. 18.9%; P = 0.003) and bowel ischemia (7.1% vs. 0.0%; P = 0.048) occurred more frequently after open repair. One patient (2.4%) in the open repair group developed spinal cord ischemia; no cases occurred after TEVAR. Rates of cerebral complications (4.8% vs. 1.9%; P = 0.445) and in-hospital mortality (7.1% vs. 11.3%; P = 0.490) did not differ significantly between open repair and TEVAR. Long-term cumulative all-cause mortality (21.4% vs. 18.9%; P = 0.915) and aorta-related mortality (2.4% vs. 1.9%; P = 0.868) were comparable, as were freedom from aorta-related events (P = 0.813). CONCLUSION: Open repair for TTAI was associated with higher procedure-related morbidity, particularly acute kidney injury and bowel ischemia, whereas long-term survival and aorta-related event rates were similar between open repair and TEVAR. These findings support the use of TEVAR as the preferred treatment modality when anatomically feasible, although larger multicenter studies are needed to better define its long-term efficacy.
引用
- Son SA, Cho JY. Long-Term Outcomes of Endovascular Versus Open Repair for Traumatic Thoracic Aortic Injury: A Single-Center Experience. Ann Vasc Surg. 2026. PMID: 42342207. doi:10.1016/j.avsg.2026.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。